Betablocker vs Placebo bei vasomotorischem Kopfschmerz: Eine doppelblinde Cross-over-Studie

1 January 1987

journal article
research article
Published by Georg Thieme Verlag KG in Deutsche Medizinische Wochenschrift (1946)

Vol. 112 (45) , 1740-1743
https://doi.org/10.1055/s-2008-1068322

Abstract

Vasomotor headaches are commonly, especially in the international literature, classified under ordinary migraine. Since beta-blockers seem to be the drug of choice in the prevention of migraine, 30 patients were given placebo and three times 40 mg propranolol in a double-blind cross-over trial. Among 24 fully assessible sets of tests only four showed a decrease in the frequency of headaches by more than 50%. In three patients the frequency actually increased over the placebo effect.

This publication has 0 references indexed in Scilit: